Goldilocks Therapeutics
Bedford, US · Founded 2018 · Delaware corporation · 1 known investors
Founders & leadership
AK
Arthur KlausnerExecutive
Board
SM
Scott MinickBoard director
KP
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 round · 2019
▶$1.2MraisedApr 2021 · 23 investors · BiotechnologyRule 506(b)
▶$1.2MraisedApr 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott MinickDirector
- Krishna PoluDirector
- Arthur KlausnerExecutive Officer, Director
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Goldilocks Therapeutics's investors?
- Goldilocks Therapeutics's investors include Red Tree Venture.
- How much funding has Goldilocks Therapeutics raised?
- Goldilocks Therapeutics has disclosed $1.2M raised across 1 round.
- Where is Goldilocks Therapeutics headquartered?
- Goldilocks Therapeutics is headquartered in Bedford, US.